SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
Over the past year we have endured the Covid-19 pandemic. Accumulating evidence suggests
that the host immunity response is contributing in severe forms COVID-19 caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 causes mild to severe
illness with high morbidity and mortality, especially in preexisting risk groups. These
immunologic reactions in severe COVID-19 may characterize the cytokine storm that is
associated with untoward clinicopathological consequences. The cytokine storm is an out-
ofcontrol cytokine release that has been observed in some infectious and noninfectious diseases,
leading to a hyperinflammation condition in the host. This immune response has been associated
with a higher intensive care unit (ICU) admissions and mortality in COVID-19. In fact, higher
concentrations of granulocyte-colony stimulating factor (G-CSF), interferon gamma-induced
protein 10 (IP10), monocyte chemo-attractant protein 1 (MCP1), macrophage inflammatory
protein lalpha (MIP1A), and tumor necrosis factor alpha (TNF ) in comparison to non-ICU
patients were reported in patients with COVID-19. In another study, higher levels of interleukin2
(IL-2) receptor, interleukin-6 (IL-6), interleukin- 8 (IL-8), interleukin-10 (IL-10), and TNF were
found in deceased patients with COVID-19 compared to patients who had recovered from the
disease. This uncontrolled cytokine response might be accompanied with more immune cells
activation including T helper 17 cell (Th17) differentiation from CD4+ lymphocytes. As you can
tell a lot is going on with the immune system with Covid-19. Your task is to describe what is
going on with this cytokine storm. What are cytokines and chemokines? What is their role in the
immune system? What is the complement system? How is it activated (think Creactive proteins)
and what is its role in the immune response? What is meant by the adaptive immune system?
What are the functions of B lymphocytes, cytotoxic T cells and helper T cells? How does the
Covid-19 vaccine work? To help you out, you can view the Michael Saag videos linked here.

Weitere ähnliche Inhalte

Ähnlich wie Over the past year we have endured the Covid-19 pandemic. Accumulatin.pdf

Sepsis
 Sepsis Sepsis

Ähnlich wie Over the past year we have endured the Covid-19 pandemic. Accumulatin.pdf (20)

ĐIỀU TRỊ ĐIỀU HÒA MIỄN DỊCH Ở BN COVID 19
ĐIỀU TRỊ ĐIỀU HÒA MIỄN DỊCH Ở BN COVID 19ĐIỀU TRỊ ĐIỀU HÒA MIỄN DỊCH Ở BN COVID 19
ĐIỀU TRỊ ĐIỀU HÒA MIỄN DỊCH Ở BN COVID 19
 
joURNAL READING BIOMARKER.pptx
joURNAL READING BIOMARKER.pptxjoURNAL READING BIOMARKER.pptx
joURNAL READING BIOMARKER.pptx
 
Cytokines in diseases
Cytokines in diseasesCytokines in diseases
Cytokines in diseases
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Cyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or VictoryCyclosporine Attenuates Covid-19: Ensnare or Victory
Cyclosporine Attenuates Covid-19: Ensnare or Victory
 
Hyper IgM Syndrome
Hyper IgM SyndromeHyper IgM Syndrome
Hyper IgM Syndrome
 
Final type-iv hypersensityvity
Final type-iv hypersensityvityFinal type-iv hypersensityvity
Final type-iv hypersensityvity
 
Cytokines in lung and pleural diseases.pptx
Cytokines in lung and pleural diseases.pptxCytokines in lung and pleural diseases.pptx
Cytokines in lung and pleural diseases.pptx
 
Lary nel abao infection immunology final report
Lary nel abao infection immunology final reportLary nel abao infection immunology final report
Lary nel abao infection immunology final report
 
Major reduction of NKT cells in patients with severe COVID-19 pneumonia
Major reduction of NKT cells in patients with severe COVID-19 pneumoniaMajor reduction of NKT cells in patients with severe COVID-19 pneumonia
Major reduction of NKT cells in patients with severe COVID-19 pneumonia
 
Tocilizumab
Tocilizumab Tocilizumab
Tocilizumab
 
Sepsis
 Sepsis Sepsis
Sepsis
 
Cytokine storm: COVID-19 KILLER
Cytokine storm: COVID-19 KILLERCytokine storm: COVID-19 KILLER
Cytokine storm: COVID-19 KILLER
 
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada SelimVitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
 
Tuberclosis
TuberclosisTuberclosis
Tuberclosis
 
Immune Responses To The Pandemic New Coronavirus (COVID-19)by Prof. Mohamed L...
Immune Responses To The Pandemic New Coronavirus (COVID-19)by Prof. Mohamed L...Immune Responses To The Pandemic New Coronavirus (COVID-19)by Prof. Mohamed L...
Immune Responses To The Pandemic New Coronavirus (COVID-19)by Prof. Mohamed L...
 

Mehr von ambritmobiles

Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
 Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
ambritmobiles
 
Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
 Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
ambritmobiles
 
PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
 PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
ambritmobiles
 
Prepare the adjusting entry for each item assuming a December 31, 202.pdf
 Prepare the adjusting entry for each item assuming a December 31, 202.pdf Prepare the adjusting entry for each item assuming a December 31, 202.pdf
Prepare the adjusting entry for each item assuming a December 31, 202.pdf
ambritmobiles
 
Part I This part is worth 6 points. Create the following tables in yo.pdf
 Part I This part is worth 6 points. Create the following tables in yo.pdf Part I This part is worth 6 points. Create the following tables in yo.pdf
Part I This part is worth 6 points. Create the following tables in yo.pdf
ambritmobiles
 

Mehr von ambritmobiles (20)

Presented below are three receivable transactions. Journalize these u.pdf
 Presented below are three receivable transactions. Journalize these u.pdf Presented below are three receivable transactions. Journalize these u.pdf
Presented below are three receivable transactions. Journalize these u.pdf
 
Premium Fender uses a standard cost system and provide the tolowing h.pdf
 Premium Fender uses a standard cost system and provide the tolowing h.pdf Premium Fender uses a standard cost system and provide the tolowing h.pdf
Premium Fender uses a standard cost system and provide the tolowing h.pdf
 
Preparation 1. Find i(t) and Vc(t) ( calculate by hand ), R=6, C=0.12.pdf
 Preparation 1. Find i(t) and Vc(t) ( calculate by hand ), R=6, C=0.12.pdf Preparation 1. Find i(t) and Vc(t) ( calculate by hand ), R=6, C=0.12.pdf
Preparation 1. Find i(t) and Vc(t) ( calculate by hand ), R=6, C=0.12.pdf
 
Preguntas informativas de evaluaci�n de salud de ATI Harold Steven.pdf
 Preguntas informativas de evaluaci�n de salud de ATI Harold Steven.pdf Preguntas informativas de evaluaci�n de salud de ATI Harold Steven.pdf
Preguntas informativas de evaluaci�n de salud de ATI Harold Steven.pdf
 
Presanted beloware the firanoal statamonts of Whispering Winds Compan.pdf
 Presanted beloware the firanoal statamonts of Whispering Winds Compan.pdf Presanted beloware the firanoal statamonts of Whispering Winds Compan.pdf
Presanted beloware the firanoal statamonts of Whispering Winds Compan.pdf
 
Practice This cartilage is tough and functions to cushion and add st.pdf
 Practice This cartilage is tough and functions to cushion and add st.pdf Practice This cartilage is tough and functions to cushion and add st.pdf
Practice This cartilage is tough and functions to cushion and add st.pdf
 
Pre-Lab questions (to be turned in before a b begins) 1. Distinguish.pdf
 Pre-Lab questions (to be turned in before a b begins) 1. Distinguish.pdf Pre-Lab questions (to be turned in before a b begins) 1. Distinguish.pdf
Pre-Lab questions (to be turned in before a b begins) 1. Distinguish.pdf
 
Presented below are four segments that have been identified by Novak .pdf
 Presented below are four segments that have been identified by Novak .pdf Presented below are four segments that have been identified by Novak .pdf
Presented below are four segments that have been identified by Novak .pdf
 
PRE-LAB EXERCISES 161 Key Termm corend in fretab fermin ifi io.tim It.pdf
 PRE-LAB EXERCISES 161 Key Termm corend in fretab fermin ifi io.tim It.pdf PRE-LAB EXERCISES 161 Key Termm corend in fretab fermin ifi io.tim It.pdf
PRE-LAB EXERCISES 161 Key Termm corend in fretab fermin ifi io.tim It.pdf
 
Prepare the journal entries for Brandon Corp. for the following dat.pdf
 Prepare the journal entries for Brandon Corp. for the following dat.pdf Prepare the journal entries for Brandon Corp. for the following dat.pdf
Prepare the journal entries for Brandon Corp. for the following dat.pdf
 
Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
 Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
Pregunta 1 1 pto Las firmas con las que una empresa se asocia p.pdf
 
Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
 Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
Pregunta de lectura 2 (10 puntos) Lee el siguiente texto y con.pdf
 
PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
 PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
PREGUNTA 1 Seleccione cinco de los siguientes casos y determin.pdf
 
Prepare the adjusting entry for each item assuming a December 31, 202.pdf
 Prepare the adjusting entry for each item assuming a December 31, 202.pdf Prepare the adjusting entry for each item assuming a December 31, 202.pdf
Prepare the adjusting entry for each item assuming a December 31, 202.pdf
 
Practice Map A 1. Label each contour line with the proper elevation u.pdf
 Practice Map A 1. Label each contour line with the proper elevation u.pdf Practice Map A 1. Label each contour line with the proper elevation u.pdf
Practice Map A 1. Label each contour line with the proper elevation u.pdf
 
Part I This part is worth 6 points. Create the following tables in yo.pdf
 Part I This part is worth 6 points. Create the following tables in yo.pdf Part I This part is worth 6 points. Create the following tables in yo.pdf
Part I This part is worth 6 points. Create the following tables in yo.pdf
 
Part BTying plutonic igneous textures to their ternary phase diagr.pdf
 Part BTying plutonic igneous textures to their ternary phase diagr.pdf Part BTying plutonic igneous textures to their ternary phase diagr.pdf
Part BTying plutonic igneous textures to their ternary phase diagr.pdf
 
Part A. Use data charity.RData, collected by Franses and Paap (2001),.pdf
 Part A. Use data charity.RData, collected by Franses and Paap (2001),.pdf Part A. Use data charity.RData, collected by Franses and Paap (2001),.pdf
Part A. Use data charity.RData, collected by Franses and Paap (2001),.pdf
 
PART A Tautologies, Contradictions, and Contingent Statements Use tr.pdf
 PART A Tautologies, Contradictions, and Contingent Statements Use tr.pdf PART A Tautologies, Contradictions, and Contingent Statements Use tr.pdf
PART A Tautologies, Contradictions, and Contingent Statements Use tr.pdf
 
Part 1. Pedigrees For the pedigrees below, look at each pedigree, cir.pdf
 Part 1. Pedigrees For the pedigrees below, look at each pedigree, cir.pdf Part 1. Pedigrees For the pedigrees below, look at each pedigree, cir.pdf
Part 1. Pedigrees For the pedigrees below, look at each pedigree, cir.pdf
 

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 

Over the past year we have endured the Covid-19 pandemic. Accumulatin.pdf

  • 1. Over the past year we have endured the Covid-19 pandemic. Accumulating evidence suggests that the host immunity response is contributing in severe forms COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 causes mild to severe illness with high morbidity and mortality, especially in preexisting risk groups. These immunologic reactions in severe COVID-19 may characterize the cytokine storm that is associated with untoward clinicopathological consequences. The cytokine storm is an out- ofcontrol cytokine release that has been observed in some infectious and noninfectious diseases, leading to a hyperinflammation condition in the host. This immune response has been associated with a higher intensive care unit (ICU) admissions and mortality in COVID-19. In fact, higher concentrations of granulocyte-colony stimulating factor (G-CSF), interferon gamma-induced protein 10 (IP10), monocyte chemo-attractant protein 1 (MCP1), macrophage inflammatory protein lalpha (MIP1A), and tumor necrosis factor alpha (TNF ) in comparison to non-ICU patients were reported in patients with COVID-19. In another study, higher levels of interleukin2 (IL-2) receptor, interleukin-6 (IL-6), interleukin- 8 (IL-8), interleukin-10 (IL-10), and TNF were found in deceased patients with COVID-19 compared to patients who had recovered from the disease. This uncontrolled cytokine response might be accompanied with more immune cells activation including T helper 17 cell (Th17) differentiation from CD4+ lymphocytes. As you can tell a lot is going on with the immune system with Covid-19. Your task is to describe what is going on with this cytokine storm. What are cytokines and chemokines? What is their role in the immune system? What is the complement system? How is it activated (think Creactive proteins) and what is its role in the immune response? What is meant by the adaptive immune system? What are the functions of B lymphocytes, cytotoxic T cells and helper T cells? How does the Covid-19 vaccine work? To help you out, you can view the Michael Saag videos linked here.